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The activity of the plasma membrane ATPase in growing yeast is increased by low pH and by glucose, con- 
ditions which result in a higher demand for proton pumping. The amount of enzyme is not significatively 
modified under these conditions. The amount of ATPase is only slightly increased by introducing extra 
copies of its gene in autonomous plasmids. In addition, the expression of the ATPase gene in a multi-copy 
plasmid causes a reduction of the copy number of the plasmid and slows growth. Therefore, overexpression 
of the ATPase is detrimental for the cell, justifying a regulatory mechanism based on increasing the catalytic 
activity and not the amount of enzyme. 
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1. INTRODUCTION 2. EXPERIMENTAL 
The yeast plasma membrane ATPase is a proton 
pump [l] essential for cell growth [2,3]. As the ac- 
tivity of the enzyme depends on the growth condi- 
tions of the cells [4-61, it was interesting to 
investigate to what extent changes in the amount of 
enzyme contribute to the observed changes in ac- 
tivity. In addition, although decreasing the amount 
of ATPase seriously impairs growth [2,3], the 
possibility of overproducing the enzyme has not 
been explored. Our results indicate that the 
amount of yeast plasma membrane ATPase is 
tightly controlled, exhibiting only minor changes 
during phenotypic and genotypic manipulations. 
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2.1. Strains and growth media 
Saccharomyces cerevisiae strain RS-16 (MATa, 
leu2-3,112, ura3-25 1,328,372) was obtained as a 
segregant of crossing strains GRF18 (MATE, 
leu2-3,112, his3-ll,15, canl, obtained from G.R. 
Fink) and FL100 (MATa, ura3-251,328,372, ob- 
tained from F. Lacroute). Strain BWGl-7A 
(MATa, adel-100, his4-519, leu2-3,112, ura3-52, 
GAL+) was obtained from L. Guarente [7]. Cells 
were grown on synthetic medium containing 2% 
glucose or galactose, 0.7% yeast nitrogen base 
without amino acids (Difco) and uracil (0.2 mM), 
adenine (0.2 mM), histidine (0.4 mM) and leucine 
(1 mM) as required. Uracil was omitted for strains 
transformed with URA3 plasmids. 
2.2. Plasmids 
YCp50 is a pBR322 derivative containing the 
yeast URA3 gene and a 2.5 kb fragment of yeast 
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DNA with origin of replication (ARS1) and cen- 
tromer (CEN4) [81. 
pCGS42 is a pBR322 derivative containing the 
URA3 gene and a 1.6 kb HindlII-HpaI fragment 
with the origin of replication of the yeast 2/zm cir- 
cle [9]. It was obtained from J. Schaum (Col- 
laborative Research, Waltham, MA). pRS-358 is a 
YCp50 derivative with a 5 kb HindlII fragment 
containing the yeast plasma membrane ATPase 
gene (PMAI) and flanking sequences [2]. pRS-49 
is a pCGS42 derivative containing the same frag- 
ment described above, pRS-99 was constructed by 
ligation of the following three fragments: (i) a 
0.75 kb EcoRI-XhoI fragment containing the 
GALl  (galactokinase gene) promoter [3]; (ii) a 
fragment of 4.2 kb extending from an XhoI site 
70 bp upstream of the ATPase initiation codon to 
the HindlII site downstream of the gene [2,3]; (iii) 
a 7.1 kb EcoRI-HindlII fragment containing most 
of plasmid pCGS42. Yeast transformation was by 
the method of Ito et al. [10]. 
2.3. Determination of plasma membrane A TPase 
activity 
Samples of about 50 mg fresh weight of cells 
were filtered from the culture medium and im- 
mediately dropped into liquid nitrogen. This 
harvesting procedure results in better preservation 
of the physiological state of the ATPase than col- 
lecting the ceils by centrifugation. A crude mem- 
brane fraction was prepared by differential 
centrifugation and the activity of the plasma mem- 
brane ATPase determined as described [4]. The 
assay medium contained 50 mM 2-(N-morpholi- 
no)ethanesulfonic a id (pH 5.7 with Tris), 5 mM 
MgClz, 5 mM NaN3 (to inhibit mitochondrial 
ATPase), 0.2 mM ammonium molybdate (to in- 
hibit acid phosphatase) and 50 mM KNO3 (to in- 
hibit vacuolar ATPase). 
2.4. Quantitative immunoassay for the A TPase 
Samples of about 50 mg fresh weight of cells 
were harvested by centrifugation, washed with 
water and homogenized as in [4]. After centrifuga- 
tion for 10 min at 3000 rpm (Sorvall SS-34 rotor), 
aliquots of supernatant containing 1/zg protein 
(quantified by the method of Bradford [11]) were 
diluted to 200/A with 0.15 M NaCI and applied to 
nitrocellulose filters with a Minifold II device 
(Schleicher & Schuell). This is a filtration manifold 
with rows ,of slots suited for quantitative den- 
sitometry. Filters were processed as described [12], 
employing as 1/1000 dilution of anti-ATPase an- 
tiserum [2] and 125I-protein A from Amersham. In 
Western blots performed under similar conditions, 
the antibody only reacted with the ATPase band of 
100 kDa. After autoradiography for 1 h at - 70°C 
with an intensifying screen, the developed film was 
scanned with a Quick Scan densitometer (Desaga, 
Heidelberg). Quantification was effected by 
measuring the height of the peaks and a linear 
response was observed in the range from 0.2 to 
2/~g protein per well. 
2.5. Quantification of  mRNA 
Total yeast RNA was prepared as in [13] and 
quantified by the absorbance at 260 nm. Samples 
of 400/A containing 10 #g RNA were denatured by 
incubation for 15 min at 65°C with 6.15 M for- 
maldehyde and then applied to nitrocellulose 
filters with the Minifold II device described above. 
Filters were processed as for Northern analysis [14] 
with 50°7o formamide in the hybridization mixture. 
The probe for the ATPase mRNA was a 0.8 kb 
EcoRI fragment internal to the gene [2] 
radiolabelled by the technique of Feinberg and 
Vogelstein [15]. In Northern blots this probe 
hybridized only with the ATPase mRNA of 
3.4 kb. The probe for the URA3 mRNA was the 
1.1 kb HindlII fragment from plasmid YEp24 [16] 
radiolabelled as above. Autoradiography was per- 
formed for 20 min without screen and the 
developed film scanned as above. A linear 
response was obtained in the range from 2 to 20/~g 
RNA per well. 
3. RESULTS AND DISCUSSION 
Francois et al. [6] have described an increase in 
plasma membrane ATPase activity during late ex- 
ponential growth and a decrease at the stationary 
phase. We have reproduced these observations and 
demonstrated that the observed changes in activity 
cannot be explained by regulation of the enzyme 
level. The levels of ATPase protein and ATPase 
mRNA are fairly constant during growth and only 
demonstrate a small decrease at the stationary 
phase (fig.l). As the level of ATPase is slightly 
lower (about 20°70) in galactose-grown cells than in 
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Fig. 1. Changes in the plasma membrane ATPase during 
yeast growth. (zx) Absorbance of the culture (660 nm); 
(A) relative plasma membrane ATPase activity; (o) 
relative amount of protein reacting with anti-ATPase 
antibody; (©) relative amount of ATPase mRNA. 
Results of a typical experiment are shown. Values are the 
average of two determinations differing by less than 
15%. The values after 14 h of growth are taken as unity. 
glucose-grown ceils (not shown), the observed 
decrease may be due to exhaustion of the glucose. 
These small effects do not preclude considering the 
ATPase gene as constitutive. 
The increase in activity during exponential 
growth seems to be caused by the progressive 
acidification of the medium [17]. The ulterior 
decrease seems a consequence of the exhaustion of 
glucose [4]. Both regulatory mechanisms may be 
related because glucose metabolism results in high 
rates of acid production and external acidity will 
increase the rate of proton diffusion into the cells. 
Therefore, a higher demand for proton pumping 
will result from both glucose and acidification. 
Both in bacteria [18] and in animal cells [19] the 
amount of plasma membrane ATPase increases in 
response to the demand for ion transport (H ÷ and 
Na ÷, respectively). Some special features of the 
yeast system may have precluded this type of 
regulation. Previous experiments showed that 
small reductions in the level of yeast plasma mem- 
brane ATPase result in drastic impairment of 
growth [2,3]. We have therefore investigated 
whether there are similar constraints for increasing 
the level of enzyme. 
A DNA fragment containing the ATPase gene 
was inserted into either a single-copy, centromeric 
plasmid (YCp50) or a multi-copy, 2u-derived 
plasmid (pCGS42). When these constructions were 
introduced into yeast only modest increases in AT- 
Pase were observed (20 and 50o70, table 1). A 
higher increase was observed for the ATPase 
mRNA (60 and 220o70), suggesting that controls at 
the level of protein synthesis and/or degradation 
prevent he ATPase from increasing proportional- 
ly to its mRNA. In addition, the observed increase 
in ATPase mRNA in the multi-copy plasmid was 
much lower than expected. The 2u-derived 
plasmids used have copy numbers of 10-30 per cell 
[9] and the activity of some enzymes cloned into 
these plasmids is elevated 7-14-fold [20]. We have 
therefore investigated the level of URA3 mRNA as 
an indirect estimation of the copy number of the 
plasmids. This gene codes for the soluble, biosyn- 
thetic enzyme orotidine-5'-phosphate carboxy- 
lyase [21] and would not be subjected to the 
regulatory constraints of the ATPase. As indicated 
in table 1, when the URA3 gene is present alone in 
the multi-copy plasmid the corresponding mRNA 
is increased about 13-fold, suggesting a high copy 
number for the plasmid. On the other hand, when 
both the URA3 and PMA1 (ATPase) genes are 
present in the same plasmid the URA3 mRNA is 
only increased about 4-fold. Therefore, the 
ATPase gene probably causes a reduction in the 
copy number of the plasmid, suggesting that it is 
deleterious for the cell. Accordingly, the growth 
rate is slightly decreased (about 20°7o) in the 
ATPase-overproducing strain. 
In order to investigate further this phenomenon 
we have placed the ATPase gene in the multi-copy 
plasmid under galactose control. This was effected 
by replacing the constitutive promoter of the 
ATPase gene by the GALl  promoter. In galactose 
medium, where the ATPase gene in the plasmid is 
expressed, the levels of ATPase and URA3 mRNA 
are only 2-fold greater than in the control strain, 
suggesting a low copy number for the plasmid 
(table 2). With a plasmid containing only the 
URA3 gene the level of URA3 mRNA is increased 
10-fold, suggesting a high copy number. On the 
other hand, in glucose medium, where the ATPase 
gene in the plasmid is not expressed, the level of 
URA3 mRNA is only slightly reduced by the 
presence of the ATPase gene on the plasmid (from 
6- to 4-times over the control, table 2). This in- 
dicates that it is the expression of the ATPase gene 
and not merely its presence in the plasmid that 
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Table 1 
Effect of increasing ene dosage with plasmids on the level of ATPase 
Plasmid Growth rate Plasma membrane URA3 




YCp50 (URA3) 0.28 "1 . . . .  1 . . . .  2" 
pRS-358 (URA3, PMA1) 0.28 1.2 1.6 - 
Multi-copy 
pCGS42 (URA3) 0.28 1.0 1.0 13.4 
pRS-49 (URA3, PMA1) 0.23 1.5 3.2 4.4 
Strain RS-16 was transformed with the indicated plasmids, grown on glucose 
medium and harvested uring the exponential phase (absorbance at 660 nm 
of 0.3-0.4). Results are the average of two determinations differing by less 
than 10%. Values between quotation marks are the reference for the relative 
values of every column. The URA3 gene is present in two copies in the 
reference strain (one in the chromosome and another in the plasmid) and 
therefore a value of "2"  was assigned for the relative level of URA3 mRNA 
causes the apparent  reduct ion in copy number.  
The copy control  system for the yeast 2u 
plasmids is based on an ampl i f icat ion mechanism, 
which increases the copy number in daughter cells 
receiving fewer copies than the mother  cell [9]. 
This means that during growth copy number 
changes cont inuously and, if this results in dif- 
ferences in growth rate, selection may occur. Over- 
product ion  of  the ATPase  seems to slow growth 
(tables 1,2) and this will result in selection of  cells 
with low copy number.  The reason for the toxicity 
of  overexpressing the ATPase  is not known. The 
enzyme is a major  component  of  the p lasma mem- 
brane, accounting for 15-20% of  the p lasma 
membrane protein [1]. Therefore,  there may be 
structural  constraints for increasing the amount  of  
Table 2 
Effect of increasing the dosage of an ATPase gene under galactose control 
Plasmid Growth rate Plasma membrane URA3 
(h- 1) ATPase 
Protein mRNA 
mRNA 
Expt 1: galactose medium 
None 0.14 "1 . . . .  1 . . . .  1" 
pCGS42 (URA3) 0.14 1.0 0.9 10.0 
pRS-99 (URA3, PMA1) 0.10 1.5 2.1 2.0 
Expt 2: glucose medium 
None 0.20 "1 . . . .  1 . . . .  1" 
pCGS42 (URA3) 0.20 1.0 1.0 6.0 
pRS-99 (URA3, PMA1) 0.20 1.0 1.1 4.0 
Strain BWG1-7A and its transformant derivatives were grown on either 
galactose or glucose media. Other conditions as in table 1 
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enzyme without affecting the integrity of the mem- 
brane. Other less abundant plasma membrane pro- 
teins, such as the uracil [22] and purine-cytosine 
[23] permeases can be easily overproduced with 
multi-copy plasmids. On the other hand, the 
plasma membrane ATPase is a major ATP con- 
sumer [24] and its overproduction may com- 
promise the energy charge of the cell. In any case, 
the limitations in modifying the amount of 
ATPase indicated by these and previous [2,3] ex- 
periments justify that in the case of yeast a change 
in the demand for ion transport is coped with by 
modulating the catalytic activity and not the 
amount of enzyme. 
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